{"id":"NCT01515748","sponsor":"Sanofi","briefTitle":"Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer","officialTitle":"A Phase III, Open-labelled, Randomised Study of Neoadjuvant Docetaxel+Oxaliplatin+S-1 (DOS) + Surgery + Adjuvant S-1 Versus Surgery + Adjuvant S-1 in Patients With Resectable Advanced Gastric Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12-30","primaryCompletion":"2019-01-21","completion":"2021-12-13","firstPosted":"2012-01-24","resultsPosted":"2020-03-02","lastUpdate":"2023-12-13"},"enrollment":530,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gastric Cancer"],"interventions":[{"type":"DRUG","name":"Docetaxel (XRP6976)","otherNames":[]},{"type":"DRUG","name":"Oxaliplatin (SR96669)","otherNames":[]},{"type":"DRUG","name":"S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + 5-chloro-2, 4-dihydroxypyridine (CDHP) (Gimeracil) + Oxo (Oteracil)","otherNames":[]}],"arms":[{"label":"Surgery + Adjuvant Chemotherapy (SC)","type":"OTHER"},{"label":"Neoadjuvant Chemotherapy +Surgery +Adjuvant chemotherapy (CSC)","type":"EXPERIMENTAL"}],"summary":"Primary Objective:\n\n\\- To compare the 3-year progression free survival (PFS) in the two treatment arms.\n\nSecondary Objectives:\n\n* Overall survival (OS).\n* Postoperative pathological stage and R0 (complete) resection rate.\n* Safety: Toxicities associated with neoadjuvant chemotherapy, surgery, morbidity/mortality, toxicity of adjuvant chemotherapy.","primaryOutcome":{"measure":"Percentage of Participants With 3-Year Progression-Free Survival (PFS), as Assessed by Response Evaluation Criteria in Solid Tumors (RECIST)1.1","timeFrame":"3 years","effectByArm":[{"arm":"Surgery + Adjuvant Chemotherapy (SC)","deltaMin":60.24,"sd":null},{"arm":"Neoadjuvant Chemotherapy +Surgery +Adjuvant Chemotherapy (CSC)","deltaMin":66.82,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0152"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":["38996201","34133211"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":57,"n":195},"commonTop":["Alopecia","Dyspepsia","Skin Hyperpigmentation","Pruritus","Peripheral Sensory Neuropathy"]}}